Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Hair transplantation for Frontal Fibrosing Alopecia may work if the disease is inactive for 2 years and with ongoing treatment to maintain results.

TCF7L2 gene polymorphism is linked to alopecia areata, but it doesn't affect the success of PRP or conventional treatments.

A woman with a new PTCH gene mutation has both Gorlin syndrome and severe hair loss.

FFA patients have fewer melanocytes and thinner skin compared to others.

Mutations in the SNRPE gene cause hereditary hair loss.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Defective T cell metabolism can cause early skin aging and poor hair follicle stem cell function.

Folliculin deficiency causes problems with cell division and positioning due to disrupted RhoA signaling and interaction with p0071.

BTNL2 helps protect hair follicles from immune attacks.

Genetic analysis is crucial for diagnosing and managing cerebral arteriopathy.

Anti-TNF therapy can cause hair loss and skin issues.

Defective protein folding due to a mutation is key in ANE syndrome.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

A new mutation in the KRT86 gene was found to cause the hair disorder monilethrix in a Han family.

A girl with citrullinemia developed pili torti, suggesting a link between the hair condition and the metabolic disorder.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

IPL treatment can significantly reduce hair in faun tail but may need local anesthesia.

The visfatin GT genotype may increase the risk of Alopecia Areata.

Certain genetic factors may contribute to frontal fibrosing alopecia in Brazil.

Skin lesions in Carney Complex are caused by a gene change in some skin cells that leads to increased pigmentation and may lead to tumors.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Foxn1 is essential for hair pigmentation by directing pigment transfer to hair cells.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

A woman with an unusual pattern of hair loss was confirmed to have Frontal Fibrosing Alopecia and treated with specific medications.

Keratinocytes can reduce the survival of certain melanoma cells, suggesting new therapy paths.

The N gene affects the protein makeup of mouse hair.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

The document's conclusion cannot be provided because the content is not available.

A WNT10A gene mutation leads to ectodermal dysplasia by disrupting cell growth and differentiation.